mesothelioma ,symptoms ,pleural mesothelioma ,mesothelioma cancer ,malignant mesothelioma ,cancer ,asbestos exposure ,treatment options ,treatment ,mesothelioma treatments ,mesothelioma lawyer ,mesothelioma diagnosis ,mesothelioma cases, lining ,legal rights ,law firm ,diseases ,disease ,diagnosis ,clinical trials ,chemotherapy ,cancers ,cancer cells ,attorneys ,asbestos fibers ,asbestos cancer ,asbestos
Wednesday, 6 July 2005
Patients with a cancer of the lining of the lung, known as malignant pleural mesothelioma (MPM), lived longer than previously reported(1), when treated with Eli Lilly and Company's Alimta(®) (pemetrexed) in combination with cisplatin, according to updated data presented at the 11th annual Conference on Lung Cancer (WCLC).Mature data presented at WCLC represent an update from trial results from
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment